Published Erratum
doi: 10.1038/s41588-023-01549-x.
Author Correction: Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk
Naomi Wilcox
1
, Martine Dumont
2
, Anna González-Neira
3
, Sara Carvalho
1
, Charles Joly Beauparlant
2
, Marco Crotti
1
, Craig Luccarini
4
, Penny Soucy
2
, Stéphane Dubois
2
, Rocio Nuñez-Torres
3
, Guillermo Pita
3
, Eugene J Gardner
5
, Joe Dennis
1
, M Rosario Alonso
3
, Nuria Álvarez
3
, Caroline Baynes
4
, Annie Claude Collin-Deschesnes
2
, Sylvie Desjardins
2
, Heiko Becher
6
, Sabine Behrens
7
, Manjeet K Bolla
1
, Jose E Castelao
8
, Jenny Chang-Claude
7
9
, Sten Cornelissen
10
, Thilo Dörk
11
, Christoph Engel
12
13
, Manuela Gago-Dominguez
14
, Pascal Guénel
15
, Andreas Hadjisavvas
16
, Eric Hahnen
17
18
, Mikael Hartman
19
20
21
, Belén Herráez
3
; SGBCC Investigators; Audrey Jung
7
, Renske Keeman
10
, Marion Kiechle
22
, Jingmei Li
23
, Maria A Loizidou
16
, Michael Lush
1
, Kyriaki Michailidou
1
24
, Mihalis I Panayiotidis
16
, Xueling Sim
19
, Soo Hwang Teo
25
26
, Jonathan P Tyrer
4
, Lizet E van der Kolk
27
, Cecilia Wahlström
28
, Qin Wang
1
, John R B Perry
5
29
, Javier Benitez
30
31
, Marjanka K Schmidt
10
32
, Rita K Schmutzler
17
18
33
, Paul D P Pharoah
1
4
, Arnaud Droit
2
34
, Alison M Dunning
4
, Anders Kvist
28
, Peter Devilee
35
36
, Douglas F Easton
37
38
, Jacques Simard
2
Collaborators,
Affiliations
Collaborators
- SGBCC Investigators:
Affiliations
- 1 Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
- 2 Genomics Center, Centre Hospitalier Universitaire de Québec-Université Laval Research Center, Québec City, Quebec, Canada.
- 3 Human Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
- 4 Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
- 5 MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
- 6 Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- 7 Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- 8 Oncology and Genetics Unit, Instituto de Investigación Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo, Spain.
- 9 Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- 10 Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
- 11 Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
- 12 Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
- 13 LIFE-Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
- 14 Cancer Genetics and Epidemiology Group, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS) Foundation, Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
- 15 Team 'Exposome and Heredity,' CESP, Gustave Roussy, INSERM, University Paris-Saclay, UVSQ, Villejuif, France.
- 16 Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus.
- 17 Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
- 18 Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
- 19 Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore City, Singapore.
- 20 Department of Surgery, National University Health System, Singapore City, Singapore.
- 21 Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore.
- 22 Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
- 23 Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore City, Singapore. lijm1@gis.a-star.edu.sg.
- 24 Biostatistics Unit, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus.
- 25 Breast Cancer Research Programme, Cancer Research Malaysia, Subang Jaya, Malaysia.
- 26 Department of Surgery, Faculty of Medicine, University of Malaya, UM Cancer Research Institute, Kuala Lumpur, Malaysia.
- 27 Family Cancer Clinic, The Netherlands Cancer Institute-Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands.
- 28 Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
- 29 Metabolic Research Laboratory, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
- 30 Human Genetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
- 31 Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
- 32 Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands.
- 33 Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
- 34 Département de Médecine Moléculaire, Faculté de Médecine, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Quebec, Canada.
- 35 Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
- 36 Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
- 37 Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. dfe20@medschl.cam.ac.uk.
- 38 Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. dfe20@medschl.cam.ac.uk.
- PMID: 37752376
- PMCID: PMC10632125
- DOI: 10.1038/s41588-023-01549-x
Item in Clipboard
Published Erratum
Author Correction: Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk
Naomi Wilcox et al.
Nat Genet.
2023 Nov.
Display options
Format
doi: 10.1038/s41588-023-01549-x.
Authors
Naomi Wilcox
1
, Martine Dumont
2
, Anna González-Neira
3
, Sara Carvalho
1
, Charles Joly Beauparlant
2
, Marco Crotti
1
, Craig Luccarini
4
, Penny Soucy
2
, Stéphane Dubois
2
, Rocio Nuñez-Torres
3
, Guillermo Pita
3
, Eugene J Gardner
5
, Joe Dennis
1
, M Rosario Alonso
3
, Nuria Álvarez
3
, Caroline Baynes
4
, Annie Claude Collin-Deschesnes
2
, Sylvie Desjardins
2
, Heiko Becher
6
, Sabine Behrens
7
, Manjeet K Bolla
1
, Jose E Castelao
8
, Jenny Chang-Claude
7
9
, Sten Cornelissen
10
, Thilo Dörk
11
, Christoph Engel
12
13
, Manuela Gago-Dominguez
14
, Pascal Guénel
15
, Andreas Hadjisavvas
16
, Eric Hahnen
17
18
, Mikael Hartman
19
20
21
, Belén Herráez
3
; SGBCC Investigators; Audrey Jung
7
, Renske Keeman
10
, Marion Kiechle
22
, Jingmei Li
23
, Maria A Loizidou
16
, Michael Lush
1
, Kyriaki Michailidou
1
24
, Mihalis I Panayiotidis
16
, Xueling Sim
19
, Soo Hwang Teo
25
26
, Jonathan P Tyrer
4
, Lizet E van der Kolk
27
, Cecilia Wahlström
28
, Qin Wang
1
, John R B Perry
5
29
, Javier Benitez
30
31
, Marjanka K Schmidt
10
32
, Rita K Schmutzler
17
18
33
, Paul D P Pharoah
1
4
, Arnaud Droit
2
34
, Alison M Dunning
4
, Anders Kvist
28
, Peter Devilee
35
36
, Douglas F Easton
37
38
, Jacques Simard
2
Collaborators
- SGBCC Investigators:
Affiliations
- 1 Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
- 2 Genomics Center, Centre Hospitalier Universitaire de Québec-Université Laval Research Center, Québec City, Quebec, Canada.
- 3 Human Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
- 4 Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
- 5 MRC Epidemiology Unit, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
- 6 Institute of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- 7 Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- 8 Oncology and Genetics Unit, Instituto de Investigación Sanitaria Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo, Spain.
- 9 Cancer Epidemiology Group, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- 10 Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
- 11 Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.
- 12 Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
- 13 LIFE-Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.
- 14 Cancer Genetics and Epidemiology Group, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS) Foundation, Complejo Hospitalario Universitario de Santiago, SERGAS, Santiago de Compostela, Spain.
- 15 Team 'Exposome and Heredity,' CESP, Gustave Roussy, INSERM, University Paris-Saclay, UVSQ, Villejuif, France.
- 16 Department of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus.
- 17 Center for Familial Breast and Ovarian Cancer, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
- 18 Center for Integrated Oncology (CIO), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
- 19 Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore City, Singapore.
- 20 Department of Surgery, National University Health System, Singapore City, Singapore.
- 21 Department of Pathology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore City, Singapore.
- 22 Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.
- 23 Genome Institute of Singapore, Agency for Science, Technology and Research, Singapore City, Singapore. lijm1@gis.a-star.edu.sg.
- 24 Biostatistics Unit, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus.
- 25 Breast Cancer Research Programme, Cancer Research Malaysia, Subang Jaya, Malaysia.
- 26 Department of Surgery, Faculty of Medicine, University of Malaya, UM Cancer Research Institute, Kuala Lumpur, Malaysia.
- 27 Family Cancer Clinic, The Netherlands Cancer Institute-Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands.
- 28 Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
- 29 Metabolic Research Laboratory, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
- 30 Human Genetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
- 31 Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
- 32 Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek hospital, Amsterdam, the Netherlands.
- 33 Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
- 34 Département de Médecine Moléculaire, Faculté de Médecine, Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Quebec, Canada.
- 35 Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands.
- 36 Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
- 37 Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. dfe20@medschl.cam.ac.uk.
- 38 Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK. dfe20@medschl.cam.ac.uk.
- PMID: 37752376
- PMCID: PMC10632125
- DOI: 10.1038/s41588-023-01549-x
Item in Clipboard
Display options
Format
No abstract available
Erratum for
-
Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk.Wilcox N, Dumont M, González-Neira A, Carvalho S, Joly Beauparlant C, Crotti M, Luccarini C, Soucy P, Dubois S, Nuñez-Torres R, Pita G, Gardner EJ, Dennis J, Alonso MR, Álvarez N, Baynes C, Collin-Deschesnes AC, Desjardins S, Becher H, Behrens S, Bolla MK, Castelao JE, Chang-Claude J, Cornelissen S, Dörk T, Engel C, Gago-Dominguez M, Guénel P, Hadjisavvas A, Hahnen E, Hartman M, Herráez B; SGBCC Investigators; Jung A, Keeman R, Kiechle M, Li J, Loizidou MA, Lush M, Michailidou K, Panayiotidis MI, Sim X, Teo SH, Tyrer JP, van der Kolk LE, Wahlström C, Wang Q, Perry JRB, Benitez J, Schmidt MK, Schmutzler RK, Pharoah PDP, Droit A, Dunning AM, Kvist A, Devilee P, Easton DF, Simard J. Wilcox N, et al. Nat Genet. 2023 Sep;55(9):1435-1439. doi: 10.1038/s41588-023-01466-z. Epub 2023 Aug 17. Nat Genet. 2023. PMID: 37592023 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
